Madeline Kane, MD, PhD
University of Miami Medical School, Miami, FL – 1978
Dr. Kane joined the University of Colorado as full-time faculty in October of
Dr. Kane’s focus is on clinical studies in Head and Neck, GI and Thyroid cancer
research. A priority in her career continues to be ensuring that medical
students, residents and fellows, and junior faculty members identify their
career focus and successfully pursue it through cancer research training
grants. She is the Medical Director of the UCCC Clinical Investigations Core
(CIC) where she oversees all clinical research studies and the management of
its day-to-day activities.
Willey CD, Kane MA, Cmelak AJ (2007) A Phase II Trial of Chemoradiation using
Docetaxel and Erythropoietin for high risk post operative Head and Neck Cancer
Patients. Intl J Radiation Oncology Biology and Physics: 1:67(5) 1324-31.
Pervez H and Kane MA (2007) Chemotherapy-induced Neutropenia. Federal
Ballonoff A, Kavanagh D, McCarter M, Kane M, Pearlman N,
Nash R, Shah RJ, Schefter, TE (2007) A Phase II trial of Preoperative
Capecitabine and Accelerated Intensity Modulated Radiotherapy in Locally
Advanced Rectal Cancer. JCO In press.
Chen C, Kane MA, Song J, Campana J, Raben A, Hu K, Harrison
L, Quon H, Dancey J, Baron A, Said S, Eckhardt SG, and Raben D (2007) A Phase I
Trial of Gefitnib in combination with Radiation or Chemoradiation for Patients
with Locally Advanced Squamous Cell Head and Neck Cancer. JCO. In press.